NASDAQ · Biotechnology

Galapagos N.V. (GLPG) Stock

$27.98 +1.71% NASDAQ: GLPG Healthcare

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.

Valuation

MetricValue
Price$27.98
Market Cap$1.84B
P/E Ratio3.57
P/B Ratio0.54
P/S Ratio1.67
EPS (TTM)$7.84
52-Week High$37.78
52-Week Low$24.74
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE16.88%
ROA14.49%
ROCE18.23%
Gross Margin98.01%
Operating Margin57.14%
Net Margin46.83%
Debt/Equity0.00
Current Ratio30.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$485.0M$241.0M$240.0M$276.0M$1.1B
Operating Profit$-166.0M$-131.0M$-88.0M$-188.0M$501.0M
Net Profit$-125.0M$-218.0M$212.0M$74.0M$321.0M
EPS$-1.91$-3.32$-0.06$1.12$4.85
Op Margin-34.1%-54.3%-36.8%-68.3%45.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.2B$4.7B$4.4B$4.1B$3.4B
Total Liabilities$2.5B$2.2B$1.6B$1.2B$171.0M
Cash$2.2B$508.0M$167.0M$64.0M$88.0M
Borrowings$27.0M$22.0M$10.0M$12.0M$7.0M

Latest News

Dow Jones Futures: Apple, Google Mask Dell, Sandisk, Micron Sell-Off; J.B. Hunt Jumps Late Investor's Business Daily · Jul 16, 2026 Sport Clips Haircuts On Pace for Significant Unit Expansion By End of 2026 PR Newswire · Jul 16, 2026 Elizabeth Warren Says Trump Chose His 'Corrupt' Crypto Profits Over Being a 'President for Working People' Benzinga · Jul 16, 2026 Parkspring Multifamily Celebrates Grand Opening of The Lucille Waco PR Newswire · Jul 16, 2026 Asian stocks mostly sink as AI worries hammer tech AFP · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-504.0M$-501.0M$-406.0M$-320.0M$-189.0M
Investing Cash Flow$483.0M$-1.3B$52.0M$138.0M$206.0M
Financing Cash Flow$3.0M$7.0M$2.0M$0$-3.0M
Net Cash Flow$90.0M$-1.7B$-341.0M$-103.0M$-5.0M
Free Cash Flow$-562.0M$-537.0M$-425.0M$-402.0M$-202.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA3.55
FCF Yield-17.76%
Quick Ratio30.30
Interest Coverage250.50
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
ASMB $26.68 +0.87% -51.53 $424.02M 0.00%
CTMX $3.37 +4.01% -24.27 $541.98M 0.00%
KYNB $7.27 +4.15% 0.16 $29.43M 0.00%
NXTC $5.00 +17.81% -0.26 $18.04M 0.00%

About Galapagos N.V.

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Galapagos N.V. is headquartered in BE.

Galapagos N.V. (GLPG) stock trades at $27.98 with a market capitalization of $1.84B. The stock is valued at a price-to-earnings (P/E) ratio of 3.57, price-to-book of 0.54, price-to-sales of 1.67. Over the past 52 weeks the stock has ranged between $24.74 and $37.78, and currently trades 25.9% below its 52-week high.

On profitability, Galapagos N.V. generates a return on equity (ROE) of 16.88%, above the typical market average, return on capital employed of 18.23%, an operating margin of 57.14%, a net profit margin of 46.83%.

Official website: www.glpg.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides